StockCIK 1503802
Karyopharm Therapeutics Inc. (KPTI): Insider Trades and Fund Holdings
In the past 12 months, Karyopharm Therapeutics Inc. insiders reported 0 open-market purchases worth $0 and 3 sales worth $2K; 0 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$2KSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 19, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 19 | Kristin AbateCAO | ▼ SELL | $2K |
| Oct 2 | Kristin AbateCAO | ▼ SELL | $450 |
| Sep 2 | Kristin AbateCAO | ▼ SELL | $38 |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Kristin Abate | CAO | 0 | $0 | 3 | $2K |
Tracked funds that report KPTI
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 108,214 | $1.06M | ▲ +2.7% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →